INTERVIEW GUIDE FOR THE EPI MANAGEMENT LEVEL GENERAL INFORMATION

Similar documents
10 th Annual African Vaccinology Course (AAVC) Cape Town 10 November 2014

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE

DRAFT CCH III. Reduction of new infections and morbidity and mortality due to communicable diseases

H1N1 Vaccine Based on CDCs ACIP Meeting, July 29, 2009

PLANNING & EVALUATION WORKBOOK. WEB: FACEBOOK:

PLANNING WORKBOOK 11 th Vaccination Week in the Americas

Guide on Access to the Yellow Fever ICG Stockpile. Emergency Campaigns. International Coordinating Group on Vaccine. Geneva, Switzerland 2012

Annex 7a. Evaluation of routine second dose measles vaccination (health facility based implementation)

WYOMING CHILDHOOD IMMUNIZATION RULES CHAPTER 7 COVERED SERVICES

Vaccine Hesitancy: Acceptance and demand of vaccines in the Americas

PLANNING & EVALUATION WORKBOOK

Executive Board of the United Nations Development Programme and of the United Nations Population Fund

Vaccination in acute humanitarian emergencies

Gavi, the Vaccine Alliance - Health System and Immunisation Strengthening (HSIS) Support Framework

CLOSING MR IMMUNITY GAPS EXPERIENCES FROM THE REGIONS MALAWI. Geoffrey Zimkambani Chirwa EPI Manager

Planning for the Novel H1N1 Influenza Vaccination Campaign

MenA vaccine Introduction Country Experience, Ethiopia

FINAL RECOMMENDATIONS ON PANDEMIC INFLUENZA

Navigating vaccine introduction: a guide for decision-makers JAPANESE ENCEPHALITIS (JE) Module 4. How should my country introduce JE vaccines?

EXPANDED PROGRAM ON IMMUNIZATION (EPI)

Vaccines Supply Shortages Challenges & Opportunities

Global call for action to ensure universal access to malaria diagnosis and treatment

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

REPUBLIC OF RWANDA MINISTRY OF HEALTH EXPANDED PROGRAM ON IMMUNIZATION MULTI-YEAR PLAN

UNIVERSITY POLICY. Revised: Contact:

Global strategy on viral hepatitis and regional action plan: monitoring framework and 10 core indicators

FIRST MEETING OF THE TECHNICAL ADVISORY GROUP ON PUBLIC HEALTH ENTOMOLOGY PAN AMERICAN HEALTH ORGANIZATION

CONSOLIDATED RESULTS REPORT

Expanded Programme on Immunization (EPI):

How to present the European Vaccine Action Plan (EVAP)

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Regional Prospective of Vaccine Procurement in SEE Countries

Please note that this draft is incomplete and likely to change before and/or after City Planning Commission review.

OXYGEN IS ESSENTIAL: A POLICY BRIEF

GAVI partners Forum, Dar es Salaam, Tanzania December 5-7, 2012

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision

Establishing a cholera stockpile: What do we need? Alejandro Costa Epidemic Readiness and Intervention

Preparing for the withdrawal of all oral polio vaccines (OPVs): Replacing trivalent OPV with bivalent OPV

Navigating vaccine introduction: a guide for decision-makers JAPANESE ENCEPHALITIS (JE) Module 5. Can my country afford a JE vaccination program?

Preparing For Pandemic Influenza: What the CDC and HHS Recommend You Can Do

ANCHORAGE AREA INTERGROUP Emerald Building 615 East 82 nd Ave. Room B8 Anchorage, AK Statement of Purpose and Guidelines

WFP and the Nutrition Decade

IMMUNISATION CHALLENGES IN FIJI AND THE PACIFIC. 10th New Zealand Immunization Conference Litiana Volavola, National EPI Programme Officer, Fiji

External Evaluation of the National Immunisation Programme in Bosnia and Herzegovina

Pandemic Flu Plan. Revision #7, September Reviewed: 5/06, 7/06, 9/06, 2/07, 12/08, 09/09 Revised: 6/06, 8/06, 9/06, 2/07, 03/09, 09/09

Dr. Collins Tabu KPA Conference, 26 th April 2018 Mombasa, Kenya

Center for Family Health Policy

LOGFRAME TEMPLATE FOR SWAZILAND. SIDA s Contributions

Environmental, Health and Safety

Principles and considerations for adding a vaccine into a national immunization programme

used for HPV vaccine delivery to identify best practices and inform efforts to improve HPV vaccine coverage nationwide.

H1N1 PANDEMIC: LESSONS LEARNT VIEWS FROM A COUNTRY RECEIVING DONATED PRODUCTS

Sudan EPI Benefits From Polio Eradication Program

20. The purpose of this document is to examine the pre-pandemic efforts and the response to the new influenza A (H1N1) virus since April 2009.

National Rift Valley Fever Contingency Plan

Midterm Review of the Global Measles and Rubella Strategic Plan W. A. Orenstein, MD SAGE Geneva, 19 October 2016

Influenza Update. Kelly L. Moore, MD, MPH Medical Director, Immunization Program TN Department of Health TPHA Epi Section September 3, 2009

Please note: Forms with PXXXX designations can be found at All other forms can be found at

achievements, challenges and financing

With the collaboration of. Helen Burchett Ulla Griffiths Sandra Mounier-Jack

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Maryland Vaccines for Children Program VACCINE MANAGEMENT PLAN

Vaccinating Adults: A Step-by-Step Guide

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

TERMS OF REFERENCE. Regional Immunization Program. Department of Family, Gender and Life Course

Vaccine shortages: Improving cooperation, communication and management Michael Sulzner

The Economic and Social Council, Recalling the United Nations Millennium Declaration13 and the 2005 World Summit Outcome, 1

LOGFRAME TEMPLATE FOR MALAWI. Linking HIV and Sexual Reproductive Health and Rights in Southern Africa ( )

SIAPS Cameroon Key Achievements

Practice Direction Standard of Practice # 5: Administration of Drugs including Vaccines

Polio and measles control: opportunities and threats for health systems

Designing publicly funded healthcare markets Note by the Russian Federation

WHO INFLUENZA VACCINE RECOMMENDATION

Meeting the MDGs in South East Asia: Lessons. Framework

Report. 10 th Meeting of the Expert Review Committee (ERC) on Polio Eradication in Nigeria

Targeted Diseases and Immunization. Strategic plan

Kigali Province East Province North Province South Province West Province discordant couples

Ensuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments

Direct beneficiaries But Women Boys Girls Total. Internally Displaced People

Introduction of New Vaccines in Latin America and the Caribbean: Decision-Making LUCIA HELENA DE OLIVEIRA AND BARBARA JAUREGUI

WHO Consultation on universal access to core malaria interventions in high burden countries: main conclusions and recommendations

6. Making a comprehensive annual national immunization plan and budget

Progress with IPV introduction Polio Partners Group PPG 16 June 2014

Global Immunization Overview. Thomas Cherian Expanded Programme on Immunization WHO, Geneva

Challenges and solutions in making evidence-based national vaccination policies and recommendations

Chapter 9 Mass Vaccination Clinics

Towards the Achievement of GHSA 2024 s Overarching Targets

An aggressive approach for measles outbreak among adolescents in Barranquilla, Colombia, 2011

Mongolia s Comprehensive Multi-Year Plan for Immunization ( )

HIV Case Based Surveillance in Jamaica. Dr. Tonia Dawkins

Lao PDR. Maternal and Child Health and Nutrition status in Lao PDR. Outline

Cost-effectiveness, Affordability, and Financing of Cervical Cancer Prevention

New Jersey Dept. of Health and Senior Services H1N1 Vaccination Program FAQs PROVIDER SITE. Date: Sept. 17, Time: 9:30 AM

Report on MCSP Support for the Polio Switch in April 2016

VERSION APPROVAL PROCESS NUMBER 1.0 Nina Schwalbe, Managing Director, Policy and Performance

Vaccine introduction guidelines

Fifth report of Committee A

BUDGET AND RESOURCE ALLOCATION MATRIX

Committed to Environment, Health, & Safety

52nd DIRECTING COUNCIL 65th SESSION OF THE REGIONAL COMMITTEE

Transcription:

1 PAN AMERICAN HEALTH ORGANIZATION INTERVIEW GUIDE FOR THE EPI MANAGEMENT LEVEL GENERAL INFORMATION Date of interview: / / Interviewer s name: Management level where this interview was completed: National ( ) Departmental/Regional ( ) Municipal/District ( ) Department/Province: Municipality/District: Health facility: Type of facility: Facility s hours of operation: Days: Area: Urban Rural Facility s vaccination hours: Days: Population of children under 1 year: Population age 1: Population of pregnant women: Total population of the health area: I. POLITICAL PRIORITY AND LEGAL FRAMEWORKS II. FINANCING 1.1 Are resources allocated for EPI management? 1.2 Are there laws, decrees or resolutions at this level that support vaccination as a public good or right? Request a copy. 1.3 Have there been changes in the healthcare model that have affected the EPI? 1.4 Has decentralization affected the EPI? 1.4.1 Financial resources? 1.4.2 Human resources? 1.4.3 Cold chain? 1.4.4 Supervision? 1.4.5 Training? 1.4.6 Other 2.1 Are there laws, decrees or resolutions at this level that ensure budget allocations? Request a copy. 2.2 What is the budget for the year being evaluated? 2.3 Which of the following EPI components are financed by the budget line? 2.3.1 Biologicals 2.3.2 Vaccines 2.3.3 Syringes 2.3.4 Supplies 2.3.5 Cold chain 2.3.6 Training 2.3.7 Social mobilization 2.3.8 Operating expenses 2.3.9 Supervision and monitoring 2.3.10 Surveillance 2.3.11 Information system 2.3.12 Research % of financing from the national budget (*applies at the national level) Other sources of financing Page 1 of 6

2 PAN AMERICAN HEALTH ORGANIZATION I II. FINANCING III. PLANNING AND PROGRAMMING 2.3.13 Evaluation 2.3.14 Other 2.4. What percentage of the EPI budget is financed with external resources? 2.5. Have investments been made to ensure that the program has the capacity to introduce new vaccines? Evaluate Determine whether the EPI is a political priority at this level. Evaluator observations: 3.1 Does the program have a manual of technical standards? Request and record the year it was last updated. 3.2 Does the EPI have a 5-year plan of action? Request and record the year it was last updated. 3.3 Is there an annual plan of action?. 3.4 Are the goals and priorities clearly defined?. 3.5 How is compliance with the plan supervised? Describe. 3.6 What is the degree of progress in implementing the plan? Estimate (percentage): 3.7 What criteria are used to establish targets for the population that should be vaccinated? 3.7.1 For new cohorts Describe. a. 100 % of the population b. Other 3.7.2 For identifying susceptible groups Describe. a. Coverage the previous year b. Analysis of vulnerable groups c. Other 3.8 What criteria are used to identify risk areas? 3.8.1 Vaccination coverage 3.8.2 Marginalized, overcrowded, or remote areas 3.8.3 Migrant populations 3.8.4 Surveillance indicators 3.8.5 Reports of cases and outbreaks 3.8.6 Other 3.9 Are activities and resources prioritized for high risk municipalities or areas? 3.10 What vaccination strategies does the regular program use? 3.10.1 Institutional vaccination by demand (passive) 3.10.2 Active search for individuals who are not vaccinated or have an incomplete vaccination schedule 3.10.3 Systematic house-to-house vaccination 3.10.4 Periodic visits to rural or remote areas for a description and mark 3.10.5 Other 3.11 What processes and instruments are used to program the needs for vaccines, syringes, and biohazard boxes? 3.12 What processes and instruments are used to program the needs for paper products (forms, vaccination cards, etc..)? 3.13 What mechanism is used for procurement of vaccines and syringes? 3.13.1 PAHO Revolving Fund for a description and mark Describe and request the instruments. Describe and request the instruments. 3.13.2 Other mechanism 3.14 Which vaccines are NOT purchased through the Revolving Fund? 3.15 Have there been any vaccine shortages? 3.16 If so, explain the reason for the shortage. Describe. Page 2 of 6

3 PAN AMERICAN HEALTH ORGANIZATION IV. ORGANIZATION AND COORDINATION V. HUMAN RESOURCES VI. COLD CHAIN 4.1 Is the EPI actively involved in key decisions? For example, decisions regarding vaccine procurement, introduction of new vaccines, resource allocation, etc. 4.2 At this level, does the EPI have vehicles in good condition available to support program activities? Observe 4.3 Does the EPI have its own physical space? Observe. 4.3.1 Telephone line (exclusive use) 4.3.2 Fax line (exclusive use) 4.3.3 Sufficient computers 4.3.4 Internet access 4.4 Is there coordination with other areas or institutions within the health sector? 4.5 Is there coordination with institutions in other sectors? 4.6 Is there an Interagency Coordinating Committee (ICC)? Indicate how often it meets. 4.7 Is there a National Advisory Committee on Immunization? Indicate how often it meets. 4.8 Are vaccinations that are carried out by other sectors or institutions reported to the EPI? 4.9 Does the EPI supervise the quality of the vaccinations performed in other sectors? 4.10 Does the EPI coordinate activities with neighboring municipalities/departments or border areas between countries? 4.10.1 Vaccination 4.10.2 Epidemiological surveillance 4.10.3 Joint plan of action 4.10.4 Other 5.1 How many people work for the EPI at this level? 5.1.1 How many of them are assigned exclusively to the EPI? 5.1.2 What is their training level? 5.1.3 What is the average seniority of team members? 5.2 If the average is under one year, indicate the reasons for this. 5.3 Has a shortage of skilled human resources affected any components of the program? 6.1 Is there a procedure for the intake of vaccines at the central warehouse?. 6.2 Is the vaccine arrival report filled out properly?. 6.3 When there is damaged packaging is it reported? Describe the procedure. 6.4 Do vaccines clear customs in less than 24 hours? Describe the procedure. 6.5 Are vaccines stored at the proper temperatures in the central warehouse?. 6.6 Are storage unit conditions adequate?. 6.7 Does the program have an up-to-date cold chain inventory? Date updated: 6.8 Is there a plan for the maintenance and replacement of equipment? 6.9 Is vaccine storage and distribution capacity adequate for the volume at this level? the inventory.. 6.10 Is there a short-term investment plan? Page 3 of 6

4 PAN AMERICAN HEALTH ORGANIZATION VII. SAFE VACCINATION VIII. INFORMATION SYSTEM 7.1 Is there a manual or educational materials on safe injection practices and final disposal of waste products?. 7.2 Is there a policy for handling and storing open vials?. 7.3 What types of syringes does the program use? 7.4 How does the program dispose of waste products? 7.4.1 They are incinerated. 7.4.2 They are collected by a biohazard waste company. 7.4.3 They are burned. 7.4.4 They are buried. 7.4.5 They are collected by the municipal dump. 7.4.6 Other 7.5 Does the program monitor events supposedly attributable to vaccination or immunization (ESAVI)? 7.6 Does the standard EPI manual include surveillance, ESAVI management, and a crisis plan? 7.7 What is the process for ESAVI surveillance? Describe. 7.8 With which entities is the response to an ESAVI coordinated? 7.8.1 National regulatory authority 7.8.2 Scientific societies 7.8.3 Legal entities 7.8.4 Advisory committee on immunization 7.8.5 ESAVI committee 7.8.6 The media 7.8.7 Reference laboratories 8.1 Which offices are responsible for managing the information systems for EPI surveillance and coverage? 8.2 How does the program establish the denominator of the population that should be vaccinated? 8.2.1 National census projections 8.2.2 Birth registries 8.2.3 Other for a description and mark 8.3 Does the EPI have a computerized nominal registry? Describe. 8.4 At this level, how soon do vaccination coverage data from the previous month become available? 8.5 What actions are implemented based on the information analysis? 8.6 What activities are undertaken to improve data quality? Describe. Observe Observe 8.7 Are other alternative sources used to confirm the denominators? 8.8 Are the registries modified to incorporate data on new vaccines? 8.9 Are coverage monitoring maps available? 8.10 Are there maps or diagrams of low coverage areas and of cases of vaccine-preventable diseases (VPD)? for a description and mark If so, what are they?. Page 4 of 6

5 PAN AMERICAN HEALTH ORGANIZATION IX. SURVEILLANCE OF VACCINE-PREVENTABLE DISEASES X - TRAINING AND SUPERVISION 9.1 Are manuals or written standards available regarding surveillance of the various VPDs? Check the year it was last updated. 9.2 Are human resources assigned to VPD surveillance? Specify the number. 9.4 Have they been given training in VPD surveillance? Year of the last training. 9.5 Do you know how many existing health facilities are reporting units? 9.6 Do other sectors participate in the network of reporting units? 9.6.1 Private sector 9.6.2 Social security 9.6.3 Military health 9.6.4 Sentinel hospitals 9.6.5 Others 9.7 Do the units report on a weekly basis? 9.8 How is the quality of negative weekly reporting verified? 9.8.1 If it is through active case searches, where are they carried out? a. In health facilities b. In the community c. Other 9.9 Is compliance with VPD surveillance indicators on eradication or elimination monitored weekly? 9.10 Is compliance with VPD surveillance indicators for new vaccines monitored monthly? Record the percentage. Request a description and mark 9.11 Are consolidated reports or bulletins on surveillance received? Which ones and how often? 9.12 Are activities coordinated between the EPI, surveillance, and laboratory? 9.13 Are analysis groups established for final classification of VPD and ESAVI cases? 10.1 Is there a systematic training program for the EPI? 10.2 Has training been provided on the introduction of new vaccines to the existing schedule? 10.3 Has training been provided in sentinel surveillance of new vaccines? 10.4 Is there an EPI supervision program? 10.5 Is sentinel surveillance of new vaccines supervised?.. Specify the participants. Request the last training program. For which vaccine(s) and the date. Date of the last training. Request the timetable and supervision guides. For what vaccine(s) and dates of last supervision. 10.6 Are the reports on supervision conducted by the EPI available? Request the reports. 10.7 Is there follow-up on the recommendations from the supervision process? How? XI. COMMUNICATION AND SOCIAL MOBILIZATION 11.1 Does the EPI have a communications plan?. 11.1.1 Is it funded? Specify the source. 11.1.2 Are communications activities carried out on an ongoing basis? 11.1.3 Is there a component for new vaccines? 11.2 Does the community participate in immunization activities? Page 5 of 6

6 PAN AMERICAN HEALTH ORGANIZATION XII. RESEARCH AND EVALUATION XIII. OPINIONS OF THE INTERVIEWEE 12.1 How often is the program evaluated at this level? 12.2 What topics are included in the evaluation? 12.2.1 Management indicators 12.2.2 VPD surveillance indicators, including new vaccines 12.3 What type of research or studies has the program carried out? 12.4 Have studies been done on the introduction of new vaccines? 13.1 What is your impression of your country s immunization program? Rate according to the response. 13.2 What is your impression of epidemiological surveillance? Rate according to the response. Excellent Excellent 13.3 In your opinion, what are the five main areas that need improvement? 1 2 3 4 5 Very Good Very Good 13.4 What lessons learned would you share in relation to the introduction of new vaccines? Identify the introduced vaccines. 1 2 3 4 5 Note the date of the last evaluation. Good Regular Poor Good Regular Poor CONCLUSIONS AND RECOMMENDATIONS Page 6 of 6